Revolutionize Precision Medicine

We unravel disease mechanisms
by identifying aberrant activities
of cell signaling pathways

15.09.2023 news

InnoSIGN receives grant of almost €700K for ovarian cancer multicenter trial

Read article All news

17.07.2023 news

Institut Gustave Roussy: OncoSIGNal predicts resistance to AR targeted drugs in mCR prostate cancer

Read article All news

16.06.2023 news

Erasmus MC: OncoSIGNal predicts response to BCG treatment of bladder cancer

Read article All news

27.04.2023 events

Racial differences in estrogen receptor signaling pathway activity in breast cancer patients

Read article All events

25.04.2023 events

Presentation of OncoSIGNal at the AACR

Read article All events

22.02.2023 events

Presentation of OncoSIGNal analysis of samples from NeoLBC breast cancer trial

Read article All events